Health care provider system for hypertensive disorders of pregnancy in Japan

Abstract

Hypertensive disorders of pregnancy (HDP) is a common but potentially life-threatening complication that affects 5-10% of all pregnancies. Due to the diverse pathologies and multiorgan dysfunction associated with HDP, multidisciplinary treatment is crucial. Moreover, HDP increases the risk of developing chronic diseases later in life and may impact offspring health. In response to these challenges, the Japan Society for the Study of Hypertension in Pregnancy (JSSHP) established the HDP health care provider certification in 2023. The aim is to increase awareness of HDP among medical professionals, expand the number of health care providers with expertise on this condition, and promote women's health through specialized care during pregnancy, postpartum, and preconception phases. The certification is open to various health care professionals involved in maternity care and requires attending a training session consisting of ten lectures. The first training session, held in September 2023, attracted over 200 participants, with 186 new HDP health care providers certified in January 2024. The majority of certified providers were midwives (49.5%) and medical doctors (36.6%), predominantly obstetricians. The ultimate objective of the HDP health care provider system is to establish a comprehensive support system for women with HDP and their families, utilizing accurate medical knowledge and evidence-based information.